Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall

Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels, (68)Ga-prostate-specific membrane antigen (PSMA) or (18)F-PSMA,...

Descripción completa

Detalles Bibliográficos
Autores principales: Soydal, Çiğdem, Demir, Burak, Sütçü, Gizem, Araz, Mine, Küçük, Nuriye Özlem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Interesting Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284183/
https://www.ncbi.nlm.nih.gov/pubmed/37337828
http://dx.doi.org/10.4274/mirt.galenos.2023.47550
Descripción
Sumario:Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels, (68)Ga-prostate-specific membrane antigen (PSMA) or (18)F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in (68)Ga-PSMA positron emission tomography/computed tomography (PET/CT), (18)F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.

Ejemplares similares